Patent · US Active

Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

US8222240B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Dieter Kadereit · Kelkheim, DE
Siegfried Stengelin · Frankfurt am Main, DE
Hubert Heuer · Frankfurt am Main, DE
Harm Brummerhop · Scheinfeld, DE

Key dates

Filing date	Dec 4, 2008
Grant date	Jul 17, 2012
Priority date	—
Expiry date	May 7, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention comprises methods for reducing plasma lipids, plasma free fatty acids (FFA), plasma glycerol and triglycerides in a mammal through the administration of certain substituted cyclopropane acid derivatives of Formula 1:wherein R1-R6 are defined herein and pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.